Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Slowing Down Stock
1083.6000 5.40 (0.50%)
NSE Aug 14, 2025 15:31 PM
Volume: 1.2M
 

1083.60
0.50%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. is trading below all available SMAs
More from Aurobindo Pharma Ltd.
Recommended